Literature DB >> 19798036

Association of blood pressure elevation and nocturnal dipping with brain atrophy, perfusion and functional measures in stroke and nonstroke individuals.

Ihab Hajjar1, Peng Zhao, David Alsop, Amir Abduljalil, Magdy Selim, Peter Novak, Vera Novak.   

Abstract

BACKGROUND: Although both blood pressure elevation and lower nocturnal dipping increase vascular risk, it is not known whether either or both are also associated with brain atrophy, cerebral perfusion, and functional status.
METHODS: We investigated the association of elevated blood pressure and nocturnal dipping based on 24-h ambulatory recordings with brain atrophy and perfusion and functional status in 80 older adults with and without stroke (age 66.4 +/- 0.8 years, 51% women, 16% nonwhite, 46% prior ischemic stroke, 55% hypertension). Anatomical and three-dimensional continuous arterial spin labeling (CASL) brain magnetic resonance imaging (MRI) measuring volumes and perfusion and 24-h ambulatory blood pressure readings were completed.
RESULTS: Nocturnal dipping of lesser magnitude in systolic (nonstroke: P = 0.03; stroke: P = 0.005) and pulse pressure (PP; nonstroke: P = 0.002; stroke: P = 0.01) was associated with greater brain atrophy, affecting preferentially the fronto-parietal regions. Dipping of lesser magnitude in systolic blood pressure (SBP; nonstroke: P = 0.01; stroke: P = 0.03) and greater brain atrophy (nonstroke: P = 0.04; stroke: P = 0.05) were also associated with slower gait speed and worse functional outcome after stroke. Higher 24-h blood pressure averages were associated with lower cerebral perfusion but not atrophy in those with and without stroke.
CONCLUSIONS: In those with and without stroke, dipping of lesser magnitude in systolic and PP is associated with brain atrophy and worse functional status. Nocturnal dipping, in addition to elevated blood pressure, should be considered as an additional important target in the clinical evaluation of those at risk for cerebrovascular disease or functional loss.

Entities:  

Mesh:

Year:  2009        PMID: 19798036      PMCID: PMC2810719          DOI: 10.1038/ajh.2009.187

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  35 in total

1.  Prediction of functional status from neuropsychological tests in community-dwelling elderly individuals.

Authors:  D A Cahn-Weiner; P F Malloy; P A Boyle; M Marran; S Salloway
Journal:  Clin Neuropsychol       Date:  2000-05       Impact factor: 3.535

2.  Prognostic value of usual gait speed in well-functioning older people--results from the Health, Aging and Body Composition Study.

Authors:  Matteo Cesari; Stephen B Kritchevsky; Brenda W H J Penninx; Barbara J Nicklas; Eleanor M Simonsick; Anne B Newman; Frances A Tylavsky; Jennifer S Brach; Suzanne Satterfield; Douglas C Bauer; Marjolein Visser; Susan M Rubin; Tamara B Harris; Marco Pahor
Journal:  J Am Geriatr Soc       Date:  2005-10       Impact factor: 5.562

3.  Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity.

Authors:  David Last; David C Alsop; Amir M Abduljalil; Robert P Marquis; Cedric de Bazelaire; Kun Hu; Jerry Cavallerano; Vera Novak
Journal:  Diabetes Care       Date:  2007-02-08       Impact factor: 19.112

Review 4.  Canadian hypertension society guidelines for ambulatory blood pressure monitoring.

Authors:  M G Myers; R B Haynes; S W Rabkin
Journal:  Am J Hypertens       Date:  1999-11       Impact factor: 2.689

5.  Ambulatory blood pressure as an independent determinant of brain atrophy and cognitive function in elderly hypertension.

Authors:  Michiaki Nagai; Satoshi Hoshide; Joji Ishikawa; Kazuyuki Shimada; Kazuomi Kario
Journal:  J Hypertens       Date:  2008-08       Impact factor: 4.844

6.  Hypertension and the risk of mild cognitive impairment.

Authors:  Christiane Reitz; Ming-Xin Tang; Jennifer Manly; Richard Mayeux; José A Luchsinger
Journal:  Arch Neurol       Date:  2007-12

7.  Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients.

Authors:  Jasper D Sluimer; Wiesje M van der Flier; Giorgos B Karas; Nick C Fox; Philip Scheltens; Frederik Barkhof; Hugo Vrenken
Journal:  Radiology       Date:  2008-06-23       Impact factor: 11.105

8.  Special article: gait measures indicate underlying focal gray matter atrophy in the brain of older adults.

Authors:  Caterina Rosano; Howard Aizenstein; Jennifer Brach; Allison Longenberger; Stephanie Studenski; Anne B Newman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2008-12       Impact factor: 6.053

9.  Cerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetes.

Authors:  Vera Novak; David Last; David C Alsop; Amir M Abduljalil; Kun Hu; Lukas Lepicovsky; Jerry Cavallerano; Lewis A Lipsitz
Journal:  Diabetes Care       Date:  2006-07       Impact factor: 19.112

10.  Association between concurrent and remote blood pressure and disability in older adults.

Authors:  Ihab Hajjar; Daniel T Lackland; L Adrienne Cupples; Lewis A Lipsitz
Journal:  Hypertension       Date:  2007-11-19       Impact factor: 10.190

View more
  23 in total

1.  Hypertension and cerebral vasoreactivity: a continuous arterial spin labeling magnetic resonance imaging study.

Authors:  Ihab Hajjar; Peng Zhao; David Alsop; Vera Novak
Journal:  Hypertension       Date:  2010-09-27       Impact factor: 10.190

Review 2.  The relationship between blood pressure and cognitive function.

Authors:  Vera Novak; Ihab Hajjar
Journal:  Nat Rev Cardiol       Date:  2010-10-26       Impact factor: 32.419

3.  Different Relationship Between Systolic Blood Pressure and Cerebral Perfusion in Subjects With and Without Hypertension.

Authors:  Lidia Glodzik; Henry Rusinek; Wai Tsui; Elizabeth Pirraglia; Hee-Jin Kim; Anup Deshpande; Yi Li; Pippa Storey; Catherine Randall; Jingyun Chen; Ricardo S Osorio; Tracy Butler; Emily Tanzi; Molly McQuillan; Patrick Harvey; Stephen K Williams; Gbenga Ogedegbe; James S Babb; Mony J de Leon
Journal:  Hypertension       Date:  2019-01       Impact factor: 10.190

4.  Dual echo vessel-encoded ASL for simultaneous BOLD and CBF reactivity assessment in patients with ischemic cerebrovascular disease.

Authors:  Carlos C Faraco; Megan K Strother; Lindsey M Dethrage; Lori Jordan; Robert Singer; Paul F Clemmons; Manus J Donahue
Journal:  Magn Reson Med       Date:  2014-04-22       Impact factor: 4.668

5.  Impact of non invasive and beat-to-beat arterial pressure monitoring on intraoperative hemodynamic management.

Authors:  Guo Chen; Elena Chung; Lingzhong Meng; Brenton Alexander; Trung Vu; Joseph Rinehart; Maxime Cannesson
Journal:  J Clin Monit Comput       Date:  2012-03-01       Impact factor: 2.502

6.  Cognition and Hemodynamics.

Authors:  Vera Novak
Journal:  Curr Cardiovasc Risk Rep       Date:  2012-10

7.  Investigation of glucose fluctuations by approaches of multi-scale analysis.

Authors:  Yunyun Lai; Zhengbo Zhang; Peiyao Li; Xiaoli Liu; YiXin Liu; Yi Xin; Weijun Gu
Journal:  Med Biol Eng Comput       Date:  2017-08-21       Impact factor: 2.602

Review 8.  Nocturnal blood pressure, morning blood pressure surge, and cerebrovascular events.

Authors:  Yuichiro Yano; Kazuomi Kario
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

9.  Associations between nocturnal blood pressure dipping and the metabolic syndrome in high- vs. low-acculturated Mexican American women.

Authors:  Smriti Shivpuri; Matthew A Allison; Caroline A Macera; Suzanne Lindsay; Linda C Gallo
Journal:  Am J Hypertens       Date:  2013-05-03       Impact factor: 2.689

10.  Association of 24-Hour Ambulatory Blood Pressure Patterns with Cognitive Function and Physical Functioning in CKD.

Authors:  Lama Ghazi; Kristine Yaffe; Manjula K Tamura; Mahboob Rahman; Chi-Yuan Hsu; Amanda H Anderson; Jordana B Cohen; Michael J Fischer; Edgar R Miller; Sankar D Navaneethan; Jiang He; Matthew R Weir; Raymond R Townsend; Debbie L Cohen; Harold I Feldman; Paul E Drawz
Journal:  Clin J Am Soc Nephrol       Date:  2020-03-26       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.